Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 28:5:12614.
doi: 10.1038/srep12614.

One-step biosynthesis of α-ketoisocaproate from L-leucine by an Escherichia coli whole-cell biocatalyst expressing an L-amino acid deaminase from Proteus vulgaris

Affiliations

One-step biosynthesis of α-ketoisocaproate from L-leucine by an Escherichia coli whole-cell biocatalyst expressing an L-amino acid deaminase from Proteus vulgaris

Yang Song et al. Sci Rep. .

Abstract

This work aimed to develop a whole-cell biotransformation process for the production of α-ketoisocaproate from L-leucine. A recombinant Escherichia coli strain was constructed by expressing an L-amino acid deaminase from Proteus vulgaris. To enhance α-ketoisocaproate production, the reaction conditions were optimized as follows: whole-cell biocatalyst 0.8 g/L, leucine concentration 13.1 g/L, temperature 35 °C, pH 7.5, and reaction time 20 h. Under the above conditions, the α-ketoisocaproate titer reached 12.7 g/L with a leucine conversion rate of 97.8%. In addition, different leucine feeding strategies were examined to increase the α-ketoisocaproate titer. When 13.1 g/L leucine was added at 2-h intervals (from 0 to 22 h, 12 addition times), the α-ketoisocaproate titer reached 69.1 g/L, while the leucine conversion rate decreased to 50.3%. We have developed an effective process for the biotechnological production of α-ketoisocaproate that is more environmentally friendly than the traditional petrochemical synthesis approach.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The deamination reaction of l-amino acid deaminase (l-AAD) from P. vulgaris.
Figure 2
Figure 2
(A) Specific growth rate of recombinant strain at different lactose-induction concentration. E. coli-pET-28a (+) (black bars), E. coli-pET-28a (+)-lad (white bars); (B) Effect of biocatalyst activity (black bars), α-ketoisocaperate (grey bars) and pH (white bars) at different induction intensities.
Figure 3
Figure 3. The effect of KIC, substrate, pH, temperature, DCW, and time on whole-cell biotransformation.
(A) Influence of KIC concentration; (B) effect of substrate concentration; (C) Influence of pH; (D) Influence of temperature; (E) Influence of biocatalyst; (F) KIC production at 0.8 g/L DCW over time.
Figure 4
Figure 4. The comparison of biocatalyst activity by whole-cell biocatalyst and production at different concentration of CCCP.
(A) biocatalyst activity at different CCCP concentration; (B) α-ketoisocaporate accumulation during bioconversion in 52.47 g/L substrate. CCCP concentration: formula image: 0 μM, formula image: 5 μM, formula image: 10 μM, formula image: 15 μM, formula image: 20 μM, formula image: 25 μM.
Figure 5
Figure 5. The effect of different feeding strategies on production of α-ketoisocaperate and biocatalyst activity.
(A) The production of α-ketoisocaperate (black bars) and biocatalyst activity (grey bars) with different initial substrate concentrations; (B) The α-ketoisocaperateproductionat different feeding interval time. formula image: 2 h, formula image: 4 h, formula image: 6 h, formula image: 8 h; formula image: 10 h.
Figure 6
Figure 6. Immobilization and recyclablilty of the whole-cell biocatalyst.
(A) Comparision of immobilization on whole-cell biocatalyst activity. (B) The comparision of the recycle ability between the free cells and immoblized cells. [straight line with square mark (formula image) for free cell and dot line with triangle mark (formula image) for immobilized cell]; Comparison of the pH (C), and thermal (D) (black bar for free and light grey bar for immobilized recombinant whole cell biocatalyst).

Similar articles

Cited by

References

    1. Aparicio M. et al. Keto acid therapy in predialysis chronic kidney disease patients: final consensus. J. Renal. Nutr. 22, S22–S24 (2012). - PubMed
    1. Aparicio M. et al. Protein-restricted diets plus keto/amino acids-a valid therapeutic approach for chronic kidney disease patients. J. Renal. Nutr. 22, S1–S21 (2012). - PubMed
    1. Mou S., Li J., Yu Z., Wang Q. & Ni Z. Keto acid-supplemented low-protein diet for treatment of adult patients with hepatitis B virus infection and chronic glomerulonephritis. J. Int. Med. Res. 41, 129–137 (2013). - PubMed
    1. Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition. 26, 482–490 (2010). - PubMed
    1. Chua B., Siehl D. L. & Morgan H. E. Effect of leucine and metabolites of branched chain amino acids on protein turnover in heart. J. Biol. Chem. 254, 8358–8362 (1979). - PubMed

Publication types

MeSH terms

LinkOut - more resources